NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/12/2026
Back to search
Official data from USPTO
PEYEONEER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PEYEONEER
ST13
US500000099374894Class
10, 42, 44
Filing
99374894
Registration
8250484
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
05/12/2026
Trademark type
Word
Nice classes
10, 42, 44
Filing date
09/04/2025
Registration date
05/12/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2026
Last transaction
05/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
26
Owner location
MAASTRICHT, NL
Examiner
PARADEWELAI, BENJI YUEN
Law office
L10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
PEYEONEER Ophthalmic Solutions B.V.
Representatives
R. Glenn Schroeder Schroeder Law PC
Technical classification
Nice Classes
Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Prosthetic intraocular implants; Artificial implantsocular implants made of artificial materials; Medical implants made of artificial materials; Ophthalmological instruments and apparatussurgical forcepsscissorsspeculumscannulasphacoemulsification handpiecesintraocular lens inserterssurgical drills for ophthalmic use; Componentsparts and fittings adapted therefor.
Class 42
Scientific and technological services and research and design services relating theretoscientific researchtechnological research in the field of ophthalmologydesign services in the fields of new science and technology products for others; Medical and pharmacological research services; Medical research in the field of ophthalmology; Design and development in the field of new medical and ophthalmological productsincluding in the field of ocular implants; Consultancy and information regarding the aforesaid services; Including the aforesaid services provided via electronic networksincluding the Internet.
Class 44
Medical services; Ophthalmological services; Medical services in the field of ophthalmological implants; Treatment of glaucoma; Consultancy and information regarding the aforesaid services; The aforesaid services also provided via electronic networksincluding the Internet
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/24/2026
PUBO
PUBLISHED FOR OPPOSITION
03/24/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/18/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/27/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2026
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/26/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/24/2026
GNFR
FINAL REFUSAL E-MAILED
02/24/2026
CNFR
FINAL REFUSAL WRITTEN
02/24/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/18/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/18/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/18/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/28/2026
GNRT
NON-FINAL ACTION E-MAILED
01/28/2026
CNRT
NON-FINAL ACTION WRITTEN
01/28/2026
DOCK
ASSIGNED TO EXAMINER
01/26/2026
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/25/2026
MAFR
APPLICATION FILING RECEIPT MAILED
09/04/2025
NWAP
NEW APPLICATION ENTERED
09/04/2025
Continuous trademark protection
Get notified about every new filing that threatens PEYEONEER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.